Fresenius Medical Care Announces Issue of Debt
Fresenius Medical Care, the leading global provider of products and services for people with chronic kidney failure, intends to issue senior unsecured bonds in the amount of $ 1.2 billion and 250 million €. The tranches will have maturities of between 7.5 and ten years. The net proceeds will be, Inc., used to repay indebtedness and for general corporate purposes including acquisitions for the acquisition by Liberty Dialysis Holdings. bond issuer will Fresenius Medical Care U.S. Finance II, Inc. and FMC Finance SA VIII. Both companies are wholly-owned subsidiary of Fresenius Medical Care AG & Co. KGaA. The bonds will be offered through a private placement to institutional investors and by Fresenius Medical Care AG & Co. KGaA and its subsidiaries, Fresenius Medical Care Holdings, Inc. and Fresenius Medical Care Germany GmbH jointly and severally guaranteed. The bond offering is not registered under the U.S. Securities Act of be registered 1933rd Instead, the placement of an "offshore transaction" conducted by Regulation S under the Securities Act and the bonds are in the U.S. "qualified institutional buyers" ("qualified institutional buyers" QIBs) - pursuant to the exemption from registration under rule 144A of the Securities Act - are offered. The bonds may be in the United States absent registration under the Securities Act or an exemption from the presence of non-registration sold. Fresenius Medical Care has applied for approval of the bonds to trading on the regulated market of the Luxembourg Stock Exchange. Fresenius Medical Care is the world's leading provider of products and services for people with chronic kidney failure, a condition of which draw more than 2 million patients a regular dialysis treatment. In 2874 a network of dialysis clinics in North America, Europe, Asia, Latin America and Africa, Fresenius Medical Care dialysis patients 228 239. Fresenius Medical Care is also the world's leading provider of dialysis products such as hemodialysis machines, dialyzers and related disposable products. Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME, FME3) and the New York Stock Exchange (FMS, FMS / P)
Fresenius Medical Care, the leading global provider of products and services for people with chronic kidney failure, intends to issue senior unsecured bonds in the amount of $ 1.2 billion and 250 million €. The tranches will have maturities of between 7.5 and ten years. The net proceeds will be, Inc., used to repay indebtedness and for general corporate purposes including acquisitions for the acquisition by Liberty Dialysis Holdings. bond issuer will Fresenius Medical Care U.S. Finance II, Inc. and FMC Finance SA VIII. Both companies are wholly-owned subsidiary of Fresenius Medical Care AG & Co. KGaA. The bonds will be offered through a private placement to institutional investors and by Fresenius Medical Care AG & Co. KGaA and its subsidiaries, Fresenius Medical Care Holdings, Inc. and Fresenius Medical Care Germany GmbH jointly and severally guaranteed. The bond offering is not registered under the U.S. Securities Act of be registered 1933rd Instead, the placement of an "offshore transaction" conducted by Regulation S under the Securities Act and the bonds are in the U.S. "qualified institutional buyers" ("qualified institutional buyers" QIBs) - pursuant to the exemption from registration under rule 144A of the Securities Act - are offered. The bonds may be in the United States absent registration under the Securities Act or an exemption from the presence of non-registration sold. Fresenius Medical Care has applied for approval of the bonds to trading on the regulated market of the Luxembourg Stock Exchange. Fresenius Medical Care is the world's leading provider of products and services for people with chronic kidney failure, a condition of which draw more than 2 million patients a regular dialysis treatment. In 2874 a network of dialysis clinics in North America, Europe, Asia, Latin America and Africa, Fresenius Medical Care dialysis patients 228 239. Fresenius Medical Care is also the world's leading provider of dialysis products such as hemodialysis machines, dialyzers and related disposable products. Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME, FME3) and the New York Stock Exchange (FMS, FMS / P)
